BRPI1007678A2 - forma de ingestão oral e uso de hidroxietilcelulose catiônica - Google Patents

forma de ingestão oral e uso de hidroxietilcelulose catiônica

Info

Publication number
BRPI1007678A2
BRPI1007678A2 BRPI1007678A BRPI1007678A BRPI1007678A2 BR PI1007678 A2 BRPI1007678 A2 BR PI1007678A2 BR PI1007678 A BRPI1007678 A BR PI1007678A BR PI1007678 A BRPI1007678 A BR PI1007678A BR PI1007678 A2 BRPI1007678 A2 BR PI1007678A2
Authority
BR
Brazil
Prior art keywords
oral ingestion
cationic hydroxyethylcellulose
ingestion form
hydroxyethylcellulose
cationic
Prior art date
Application number
BRPI1007678A
Other languages
English (en)
Inventor
Turowski Maciej
A Young Scott
Hung Shao-Ching
H Kerr Anderson W
h yokoyama Wallace
T Sttot William
Original Assignee
Dow Global Technologies Llc
The Unites States Of America As Represented By The Secretary Of Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Llc, The Unites States Of America As Represented By The Secretary Of Agriculture filed Critical Dow Global Technologies Llc
Publication of BRPI1007678A2 publication Critical patent/BRPI1007678A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI1007678A 2009-05-08 2010-05-06 forma de ingestão oral e uso de hidroxietilcelulose catiônica BRPI1007678A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17661109P 2009-05-08 2009-05-08
US17816209P 2009-05-14 2009-05-14
PCT/US2010/033890 WO2010129788A2 (en) 2009-05-08 2010-05-06 Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
BRPI1007678A2 true BRPI1007678A2 (pt) 2019-09-24

Family

ID=42830642

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007678A BRPI1007678A2 (pt) 2009-05-08 2010-05-06 forma de ingestão oral e uso de hidroxietilcelulose catiônica

Country Status (7)

Country Link
US (1) US20100331278A1 (pt)
EP (1) EP2427197A2 (pt)
JP (1) JP2012526141A (pt)
KR (1) KR20120016131A (pt)
CN (1) CN102421442A (pt)
BR (1) BRPI1007678A2 (pt)
WO (1) WO2010129788A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6266347B2 (ja) * 2012-01-16 2018-01-24 ライオン株式会社 メタボリックシンドローム罹患リスク判定用マーカーペプチドおよびその用途
CN102561081A (zh) * 2012-02-08 2012-07-11 泰安瑞泰纤维素有限公司 羟乙基阳离子纤维素提纯方法
JP6196034B2 (ja) * 2012-12-20 2017-09-13 ライオン株式会社 高血糖リスク判定用マーカーペプチドおよびその用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472840A (en) * 1965-09-14 1969-10-14 Union Carbide Corp Quaternary nitrogen-containing cellulose ethers
US4767463A (en) * 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5962015A (en) * 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Stabilized liposomes
US6899892B2 (en) * 2001-12-19 2005-05-31 Regents Of The University Of Minnesota Methods to reduce body fat
AU2003293207A1 (en) * 2002-11-27 2004-06-23 Kobo Products, Inc. Density-controlled particulate suspensions for foodstuff, cosmetic, pharmaceutical and other uses
US20060052338A1 (en) * 2004-08-30 2006-03-09 Gentry Mullins John J N-Acyl and quaternary ammonium modified polysaccharide fibers
US20060052339A1 (en) * 2004-08-30 2006-03-09 Mullins John J G N-acyl modified polysaccharides and pharmaceutical compositions comprising same and dietary calcium
WO2006082643A1 (ja) * 2005-02-03 2006-08-10 Taiyo Kagaku Co., Ltd. 糖尿病および／または糖尿病性腎症の予防、改善、または治療用組成物
US8597709B2 (en) * 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
BRPI0614198A2 (pt) * 2005-08-01 2011-06-07 Cp Kelco Us Inc composição lìquida
US20070082026A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for reducing food intake and controlling weight
US20070098763A1 (en) * 2005-10-11 2007-05-03 Sinnott Robert A Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
EP2079476B1 (en) * 2006-10-20 2014-05-21 Dow Global Technologies LLC Uses of hydroxypropyl methylcellulose for preventing or treating metabolic syndrome

Also Published As

Publication number Publication date
KR20120016131A (ko) 2012-02-22
WO2010129788A3 (en) 2011-02-24
CN102421442A (zh) 2012-04-18
US20100331278A1 (en) 2010-12-30
WO2010129788A2 (en) 2010-11-11
EP2427197A2 (en) 2012-03-14
JP2012526141A (ja) 2012-10-25

Similar Documents

Publication Publication Date Title
BRPI0913822A2 (pt) forma farmacêutica oral e uso da forma farmacêutica
BR112012013148A2 (pt) formulação farmacêutica e uso
BR112012004176A2 (pt) implemento para cuidado oral
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BR112012002331A2 (pt) composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BRPI0917126A2 (pt) implemento para cuidado oral
BRPI0912213A2 (pt) preparação cosmética
BRPI0914713A2 (pt) composição para cuidado oral
BRPI0822833A2 (pt) Implemento para cuidado oral
BRPI0822817A2 (pt) Implemento para cuidado oral
BRPI1007494A2 (pt) composto e uso do mesmo
BRPI0816350A2 (pt) Composições orais, produtos e métodos de uso
BRPI1013421A2 (pt) composição parasticida tópica, e, uso de uma composição
BRPI1005931A8 (pt) associação de compostos, uso de uma associação, produto em forma de kit, uso de um produto e composição farmacêutica
BRPI1005670A2 (pt) composições adjuvantes e métodos de uso
BR112013016207A2 (pt) composições para cuidados orais
BRPI0822868A2 (pt) implemento para cuidado oral
DK2194959T3 (da) Skummedygtig mundplejetilberedning
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
BRPI0920222A2 (pt) composições catalisadoras e métodos de produção e uso das mesmas
BRPI0922653A2 (pt) preparação farmacêutica
BRPI1011036A2 (pt) uso
SMT201500273B (it) Diidroetorfine e loro preparazione
EP2269612A4 (en) EYE DROP PREPARATION AND ITS USE
BR112012000383A2 (pt) composições farmacêuticas e formas sólidas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.